Arrowhead Pharmaceuticals (ARWR) Q4 2025 Earnings

25NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.39
-0.01
1.37
2.75

Details

Expected EPS
-0.111567
Actual EPS
-0.11
Surprise EPS
0
Surprise Percent
+1.4%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.11 per share for Q4 2025.

0 Comments

Share your thoughts